A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

Clinical trial NCT05549323 · TERMINATED

Trial details

NCT number: NCT05549323
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2022-11-07
Primary completion: 2025-11-11
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.